Effects of co-administration of artesunate and amodiaquine on some cardiovascular disease indices in rats

Food and Chemical Toxicology

Volumn 49, Issue 1, 2011, Pages 45-48

  Adebayo, J O ^a   Igunnu, A ^a   Arise, R O ^a   Malomo, S O ^a  

^a UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

Antimalarial; Cardiovascular; Cholesterol; Heart; Toxicity

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; AMODIAQUINE; ARTESUNATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ISCHEMIC HEART DISEASE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; AMODIAQUINE; ANIMALS; ARTEMISININS; CARDIOVASCULAR DISEASES; CHOLESTEROL; MALONDIALDEHYDE; MYOCARDIUM; RATS;

ANIMALIA; ARTESUNATE; RATTUS;

EID: 78650273337     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.09.022     Document Type: Article

References (35)

1. Adjuik M., Agramey P., Babike A. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 2002, 359(9315):1365.
2. Ahamed Z., King E.J. Kinetics and plancental alkaline phosphatase. Biochim. Biophys. Acta 1959, 34:313.
3. Ajani O., Shallie P.D., Adegbesan B.O., Salau B.A., Adesanya M. Protective effect of Garcinia Kola (Kolaviron) extract on predisposition of rats to cardiovascular diseases following separate administration of amodiaquine and artesunate. Afr. J. Tradit. Complement. Altern. Med. 2008, 5(2):180-186.
4. Akanji M.A., Olagoke O.A., Oloyede O.B. Effect of chronic consumption of metabisulphite on the integrity of the rat kidney cellular system. Toxicology 1993, 81:173-179.
5. Albers J.J., Warmick G.R., Cheung M.C. Quantitation of high - density lipoproteins. Lipids 1978, 13:926-932.
6. Assmann G., Schulte H. Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular münster study. Am. J. Cardiol. 1992, 70:10H-13H.
7. Assmann G., Jabs H.U., Kohnert U., Nolte W., Schriewer H. Low density lipoprotein - cholesterol method. Clin. Chem. Acta 1984, 140:77-83.
8. Brain R.I., Kay K.O. Kidney phosphatase II: the enzyme in disease. Biochem. J. 1927, 21:1103-1104.
9. Butterworth P.J., Moss D.W. Action of neuraminidase on human kidney alkaline phosphatase. Nature 1966, 209:805-810.
10. Collins A.J., Lewis D.A. Lysosomal enzyme level in blood of arthritic rats. Biochem. Pharmacol. 1971, 28:251-253.
11. Cotran K.C. Cellular Pathology. Robbins Pathologic Basis of Disease 1999, Elsevier, UK, p. 40. fifth ed.
12. Ekanem T., Salami E., Ekong M., Eluwa M., Akpanta A. Combination therapy antimalarial drugs, mefloquine and artequin, induce reactive astrocytes formation in the hippocampus of rats. Internet J. Health 2009, 9(2).
13. Fredrickson D.S., Levy R.I., Lees R.S. Monoreagent enzymatic cholesterol. N. Engl. J. Med. 1967, 276:148-156.
14. Glueck C.J., Segal P. Ratios and risk of coronary heart disease. J. Am. Med. Assoc. 1986, 255:955.
15. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease: the Framingham study. Am. J. Med. 1977, 62:707-714.
16. Hastings I.M., Watkins W.M., White N.J. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. B-Biol. Sci. 2002, 357:505-519.
17. Kazi-Aoul T., Benmiloud M. The Friedewald Formula: Another Restriction?. Clin. Chem. 1987, 33(7):1301.
18. Kunitomo M. Oxidative stress and atherosclerosis. Yakughaku zasshi 2007, 12:1997-2014.
19. Malomo S.O., Ale O.O., Adeodoyin A.M. Effect of chloroquine on some leukocyte enzymes during protein energy malnutrition - an in vitro study. Biosci. Res. Commun. 1993, 5:53-55.
20. Malomo S.O., Daramola A.S., Balogun E.A. Some serum and tissue enzyme changes in mice infected with Plasmodium yoelii nigeriensis before and after administration of halofantrine hydrochloride. Nig. J. Biochem. Mol. Biol. 1995, 10:71-77.
21. Montgomery D.C. Design and analysis of experiment 1976, John Wiley, New York, pp. 48-50.
22. Morakinyo A.O., Oludare G.O., Ojulari S., Afolabi A.O. Effects of short term administration of artemether - lumefantrine on testicular functions and antioxidant defence in the rat. Res. J. Med. Med. Sci. 2009, 4(2):165-170.
23. Narayanan C.R., Joshi D.D., Maunder A.M. Hypoglycemic action of Bougainvillea spectabilis leaves. Curr. Sci. 1984, 53:579-581.
24. National Research Council, 1996. Institute of Laboratory Animal Resources Commission in Life Sciences. National Academy Press, Washington, DC.
25. Ngaha E.O., Akanji M.A., Madusolomo M.A. Studies on correlation between chloroquine-induced tissue damage and serum changes in rats. Experimentia 1989, 45:143.
26. Nosten F., Van vugt M., Price R., Luxemburger C., Thyway K.L., Brockman A., Mc Gready R., Terkuile F., Looareesuwan S., White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 2000, 356:297-302.
27. Obianime A.W., Aprioku J.S. Comparative study of artesunate, ACTs and their combinants on the biochemical parameters of male guine.a-pigs. Afr. J. Biotechnol. 2009, 8(19):5059-5065.
28. Ogbu S.I., Okechukwu E.I. The effect of storage temperature prior to separation on plasma and serum potassium. J. Med. Lab. Sci. 2001, 10:1-4.
29. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434(7030):214-217.
30. Timothy M.E., Davis H.A., Kenneth F.I. Artemisinin-based combination therapies for uncomplicated malaria. MJA 2005, 182(4):181-185.
31. Traebert M., Dumotier B. Antimalarial drugs: QT prolongation and cardiac arrhythmias. Expert Opin. Drug Saf. 2005, 4(3):421-431.
32. Varshey R., Kale R.K. Effect of calmodulin antagonist on radiation induced lipid peroxidation in microsome. Int. J. Rad. Biol. 1990, 58:733-743.
33. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 2001, 184:770-776.
34. World Health Organisation (1994). The role of artemisinin and its derivatives in the current treatment of malaria. Geneva, 1067.
35. Wright P.J., Plummer D.T. The use of urinary enzyme measurement to detect renal damage caused by nephritic compounds. Biochem. Pharmacol. 1974, 23:65-73.